期刊文献+

MDM2在原发性肝细胞癌中的表达 被引量:5

EXPRESSION OF MDM2 IN PRIMARY HEPATOCELLULAR CARCINOMA
下载PDF
导出
摘要 目的检测MDM2蛋白及其mRNA在原发性肝细胞癌中的表达,探讨MDM2在原发性肝细胞癌发生发展中作用及意义。方法采用免疫组织化学、原位分子杂交和细胞图像分析技术,检测肝细胞癌组织及其对应癌旁肝组织(各20例),正常肝组织(5例)中MDM2蛋白及其mRNA表达情况。结果在肝细胞癌组织、癌旁肝组织和正常肝组织中,MDM2蛋白免疫组织化学阳性反应颗粒的平均光密度分别为0404±0105,0302±0067,0087±0034。肝细胞癌组织与癌旁肝组织、正常肝组织相比,差异均有显著性意义(P<005)。MDM2mRNA在肝细胞癌组织中呈阳性表达,而癌旁肝组织及正常肝组织均呈阴性。结论MDM2过度表达在原发性肝细胞癌的发生发展过程中可能发挥了重要作用。 ? Objective To investigate proteinand mRNAexpressions of MDM2and their role in the carcinogenesis and development of primary hepatocellular carcinoma. Methods The expressions of MDM2 protein and mRNA in hepatocellular carcinoma tissues, para carcinoma liver tissues (twenty cases each) and normal liver tissues (five cases)were detected by immunohistochemistry, in situ hybridizationand cell image analysis. Results In hepatocellular carcinoma tissues, para carcinoma liver tissues and normal liver tissues, the average optical density of MDM2 protein positiveimmunostaining was 0 404±0 105, 0 302±0 067 and 0 087±0 034, respectively. The MDM2 protein positive expressionin hepatocellular carcinoma tissues showed significant difference from that inpara carcinoma liver tissues and normal liver tissues( P <0 05). The expression of MDM2 mRNA was positive in hepatocellular carcinoma tissues, while, in contrast, such expression was not observed in para carcinoma liver tissues and normal liver tissues. Conclusion The overexpression of MDM2 may play an important role in thecarcinogenesis anddevelopment of primary hepatocellular carcinoma. 〔
出处 《中国组织化学与细胞化学杂志》 CAS CSCD 2004年第4期503-506,共4页 Chinese Journal of Histochemistry and Cytochemistry
基金 江西省卫生厅资助课题(200217)
关键词 原发性肝细胞癌 MDM2 免疫组织化学 原位分子杂交 Primary hepatocellular carcinoma MDM2 Immunohistochemistry In situ hybridization
  • 相关文献

参考文献2

二级参考文献17

  • 1崔大祥,范清宇,阎小君,吉昌华,苏成芝.骨组织恶性肿瘤与癌基因mdm2、c-myc和抗癌基因p53关系的研究[J].中华骨科杂志,1997,17(2):124-126. 被引量:2
  • 2崔大祥,范清宇,阎小君,苏成芝,吉昌华.骨恶性肿瘤与mdm2 nm23-H_1关系的研究[J].第四军医大学学报,1997,18(1):20-22. 被引量:2
  • 3Ladanyi M,Cancer Res,1993年,53卷,1期,16页
  • 4Juven Gershon T, Oren M. Mdm2 : the ups and downs [J]. Mol Med, 1999, 5(2): 71-83.
  • 5Momand J, Jung D, Wilczynski S, et al. The MDM2 gene amplification database[J]. Nucleic Acids Res, 1998, 26(15): 3453-3459.
  • 6Garcia Echeverria C, Chene P, Blommers MJ, et al. Discovery of potent antagonists of the interaction between human double minute 2 and tumor suppressor p53[J]. J Med Chem, 2000, 43(17): 3205-3208.
  • 7Mayo LD, Turchi JJ, Berberich SJ. Mdm-2 phosphorylation by DNA-dependent protein kinase prevents interaction with p53[J]. Cancer Res, 1997, 57(22): 5013-5016.
  • 8Zhang Y, Xiong Y, Yarbrough WG. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways[J]. Cell, 1998, 92(6): 725-734.
  • 9Lane DP, Hall PA. MDM2-arbiter of p53's destruction[J]. Trends Biochem Sci, 1997, 22(10): 372-374.
  • 10Bottger A, Bottger V, Garcia Echeverria C, et al. Molecular characterization of the hdm2-p53 interaction[J]. J Mol Biol, 1997, 269(5): 744-756.

共引文献13

同被引文献120

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部